Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Get research updatesThis study is active but not recruiting in China. It is testing esketamine for depression.
Listed age limits: from 18 years.
Compensation and expense reimbursement have not been verified for this summary.
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Changsha · Nanjing · Hangzhou
A listed location does not confirm current availability.
The study sponsor is Peking University First Hospital, a university.
Yes. The study involves medication, including Esketamine and Placebo.
Listed age limits: from 18 years.
The registry lists this study as active, but no longer recruiting.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me